ResearcherActive in the last 2 years

Adrien Grancher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2338-891X; OpenAlex author ID A5076482035. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma. Co-author DOI 10.1016/j.clinre.2025.102583 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Frédéric Di Fiore · 1 shared paper, 2025 · strength 0.26
- Paper Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metasta… DOI 10.1016/j.clinre.2025.102583 ↗
Lilian Schwarz · 1 shared paper, 2025 · strength 0.26
- Paper Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metasta… DOI 10.1016/j.clinre.2025.102583 ↗
Pierre Michel · 1 shared paper, 2025 · strength 0.26
- Paper Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metasta… DOI 10.1016/j.clinre.2025.102583 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.